AI assistant
Sending…
ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2025
Feb 6, 2025
33148_dirs_2025-02-05_93abe882-90f8-4d68-a0f4-757c7df52a62.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2025-01-27
Reporting Person: Pratumsuwan Piratip (N/A)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $24.82 | 2030-08-03 | Common Stock (20000) | Direct |
More from ROCKET PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20